In order to address these challenges, we developed a novel digital assay known as Tissue Insight for the quantification of PD-L1 (22C3) in tumor cells and macrophages of NSCLC (TI 22C3 NSCLC DA). This evidence concerns the gene CD274 and non-small cell lung carcinoma.